Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
About the study
Primary Objective:
To explore associations between biomarkers of atopic dermatitis (AD) and:
Disease state and time course of AD,
Disease state and evolution of selected atopic comorbid conditions,
Effectiveness of specific AD treatments.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion criteria:
- Participation in the OBS15333 pediatric atopic dermatitis (AD) registry.
- Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age.
EXCLUSION CRITERIA
Exclusion criteria:
Not applicable.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Dermatitis Atopic
Age (in years)
< 11
Participants needed
161
Est. Completion Date
Sep 30, 2026
Treatment type
Observational [Patient Registry]
Sponsor
Sanofi
ClinicalTrials.gov identifier
NCT03849716
Study number
LPS15496
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?